Fascioscapulohumeral muscular dystrophy: A progressive degenerative disease that responds to diltiazem

Medical Hypotheses

Volumn 65, Issue 4, 2005, Pages 716-721

  Lefkowitz, D L ^a,b   Lefkowitz, S S ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; VERAPAMIL;

APOPTOSIS; ARTICLE; CALCIUM BLOOD LEVEL; CELL DEATH; CELL DISRUPTION; CELL MEMBRANE PERMEABILITY; CELL ORGANELLE; CLINICAL TRIAL; DEGENERATIVE DISEASE; DRUG RESPONSE; DUCHENNE MUSCULAR DYSTROPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; HUMAN; HYPOTHESIS; MEMBRANE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MUSCLE ATROPHY; MUSCLE CELL; MUSCULAR DYSTROPHY; NECROSIS; NONHUMAN; PRIORITY JOURNAL;

ADENINE NUCLEOTIDE TRANSLOCATOR 1; CALCIUM; DILTIAZEM; HUMANS; MITOCHONDRIAL MEMBRANES; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; TUMOR NECROSIS FACTOR-ALPHA;

FORMICIDAE;

EID: 22544467783     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.04.035     Document Type: Article

References (54)

1. A.E. Emery The muscular dystrophies Lancet 359 2002 687 695
2. R. Tawil, M.P. McDermott, J.R. Mendell, J. Kissel, and R.C. Griggs Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group Neurology 44 1994 442 446
3. MDA Publications. Facioscapulohumeral muscular dystrophy.
4. MDA Publications. Neuromuscular diseases in the MDA program.
5. C. Angelini Advances and perspectives in muscular dystrophies Basic Appl Myol 12 2002 17 25
6. C. Wijmenga, S.T. Winokur, G.W. Padberg, M.I. Skraastad, M.R. Altherr, and J.J. Wasmuth The human skeletal muscle adenine nucleotide translocator gene maps to chromosome 4q35 in the region of the facioscapulohumeral muscular dystrophy locus Hum Genet 92 1993 198 203
7. R. Tupler, G. Perini, M.A. Pellegrino, and M.R. Green Profound misregulation of muscle-specific gene expression in facioscapulohumeral muscular dystrophy Proc Natl Acad Sci USA 96 1999 12650 12654
8. D. Gabellini, M.R. Green, and R. Tupler Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle Cell 110 2002 339 348
9. D. Laoudj-Chenivesse, G. Carnac, C. Bisbal, G. Hugon, S. Bouillot, and C. Desnuelle Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle J Mol Med 2004 Internet publication November 17
10. E.W. Yeung, and D.G. Allen Stretch-activated channels in stretch-induced muscle damage: role in muscular dystrophy Clin Exp Pharmacol Physiol 31 2004 551 556
11. A.N. Martonosi, and S. Pikula The network of calcium regulation in muscle Acta Biochim Pol 50 2003 1 30
12. G. Beutner, V.K. Sharma, D.R. Giovannucci, D.I. Yule, and S.S. Sheu Identification of a ryanodine receptor in rat hear mitochondria J Biol Chem 276 2001 21482
13. Reynolds I. Mechanisms for manipulating intracellular calcium buffering. Technical Support TOCRIS; 1999.
14. 2+ homeostatsis and impaired mitochondrial function in cardiomyopathy Mol Cell Biochem 238 2002 119 127
15. M.K. Bauer, A. Schubert, O. Rocks, and S. Grimm Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis J Cell Biol 147 1999 1493 1502
16. M.W. Berchtold, H. Brinkmeier, and M. Muntener Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease Physiol Rev 80 2000 1215 1265
17. K.G. Culligan, and K. Ohlendieck Abnormal calcium handling in muscular dystrophy Basic Appl Myol 12 2002 147 157
18. I.M. Gommans, M.H. Vlak, A. de Haan, and B.G. van Engelen Calcium regulation and muscle disease J Muscle Res Cell Motil 23 2002 59 63
19. O. Friedrich, M. Both, J.M. Gillis, J.S. Chamberlain, and R.H. Fink Mini-dystrophin restores L-type calcium currents in skeletal muscle of transgenic mdx mice J Physiol 555 2004 251 265
20. 2+ channel by the actin-binding proteins alpha-actinin and dystrophin Am J Physiol Cell Physiol 282 2002 C1502 C1511
21. 2+ homeostasis in skeletal muscle cells J Clin Invest 10 1997 1440 1447
22. G.S. Pall, K.J. Johnson, and G.L. Smith Abnormal contractile activity and calcium cycling in cardiac myocytes isolated from DMPK knockout mice Physiol Genomics 13 2003 139 146
23. F. Galbiati, J.A. Engelman, D. Volonte, X.L. Zhang, C. Minetti, and M. Li Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities J Biol Chem 276 2001 21425 21433
24. M. Sandri Apoptotic signaling in skeletal muscle fibers during atrophy Curr Opin Clin Nutr Metab Care 5 2002 249 253
25. R.W. Jackman, and S.C. Kandarian The molecular basis of skeletal muscle atrophy Am J Physiol Cell Physiol 287 2004 C834 C843
26. C. Winkelman Inactivity and inflammation: selected cytokines as biologic mediators in muscle dysfunction during critical illness AACN Clin Issues 15 2004 74 82
27. D.L. Lefkowitz, M.P. Gelderman, S.R. Fuhrmann, S. Graham, J.D. Starnes III, and S.S. Lefkowitz Neutrophilic myeloperoxidase-macrophage interactions perpetuate chronic inflammation associated with experimental arthritis Clin Immunol 91 1999 145 155
28. S. Kuru, A. Inukai, T. Kato, Y. Liang, S. Kimura, and G. Sobue Expression of tumor necrosis factor-alpha in regnerating muscle fibers in inflammatory and non-inflammatory myopathies Acta Neuropathol 105 3 2003 217 224
29. Z. Mackiewicz, M. Hukkanen, D. Povilenaite, A. Sukura, J.E. Fonseca, and I. Virtanen Dual effects of caspase-1, interleukin-1 beta, tumour necrosis factor-alpha and nerve growth factor receptor in inflammatory myopathies Clin Exp Rheumatol 21 2003 41 48
30. N. Watanabe Clincal significance of measurement of circulating tumor necrosis factor alpha Rinsho Byori 48 2001 829 833
31. A. Mammarella, P. Ferroni, M. Paradiso, F. Martini, V. Paoletti, and S. Morino Tumor necrosis factor-alpha and myocardial function in patients with myotonic dystrophy type1 J Neurol Sci 201 2002 59 64
32. M.D. Grounds, and J. Torrisi Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis FASEB J 18 2004 676 682
33. Y. Takaoka, M. Takamori, M. Ichinose, M. Tsujihata, M. Mori, and K. Eguchi A protein anabolic factor from porcine pancreas and its affects on mice and patients with progressive muscular dystrophy IRCS J Med Sci 5 1977 103 105
34. A. Tomomura, T. Fukushige, T. Noda, T. Noikura, and T. Saheki Serum calcium-decreasing factor (caldecrin) from porcine pancreas has proteolytic activity which has no clear connection with the calcium decrease FEBS Lett 301 1992 277 281
35. A. Tomomura, H. Yamada, K. Fujimoto, A. Inaba, and S. Katoh Determination of amino acidsequence responsible for suppression of bone resorption by serum calcium-decreasing factor (caldecrin) FEBS Lett 508 2001 454 458
36. C. Vandebrouck, N. Imbert, B. Constantin, G. Duport, G. Raymond, and C. Cognard Normal calcium homeostasis in dystrophin-expressing facioscapulohumeral muscular dystrophy myotubes Neuromuscul Disord 12 2002 266 272
37. O.H. Petersen Calcium signal compartmentalization Biol Res 35 2002 177 182
38. O.H. Petersen Calcium signal compartmentalization Acta Neuropathol 115 2003 217 224
39. M. Sandri, A.H. El Meslemani, C. Sandri, P. Schjerling, K. Vissing, and J.L. Andersen Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulohumeral muscular dystrophy. A potential target for pharmacological treatment? J Neuropathol Exp Neurol 60 2001 302 312
40. N. Yamaguchi, and M. Kasai Identification of 30 kDa calsequestrin-binding protein, which regulates calcium release from sarcoplasmic reticulum of rabbit skeletal muscle Biochem J 335 Pt 3 1998 541 547
41. N. Yamaguchi, T. Kagari, and M. Kasai Inhibition of the ryanodine receptor calcium channel in the sarcoplasmic reticulum of skeletal muscle by an ADP/ATP translocator inhibitor, atractyloside Biochem Biophys Res Commun 258 1999 247 251
42. P. Lestienne, N. Bataille, and B. Lucas-Heron Role of the mitochondrial DNA and calmitine in myopathies Biochim Biophys Acta 1271 1995 159 163
43. J. Cuschieri, D. Gourlay, I. Garcia, S. Jelacic, and R.V. Maier Slow channel calcium inhibition blocks proinflammatory gene signaling and reduces macrophage responsiveness J Trauma 52 2002 434 442
44. B. Rethi, C. Detre, P. Gogolak, A. Kolonics, M. Magocsi, and E. Rajnavolgyi Flow cytometry used for the analysis of calcium signaling induced by antigen-specific T-cell activation Cytometry 47 2002 207 216
45. S. Orrenius, B. Zhivotovsky, and P. Nicotera Regulation of cell death: the calcium-apoptosis link Nat Rev Mol Cell Biol 4 2003 552 565
46. T.E. Bertorini, G.M. Palmieri, J.W. Griffin, M. Igarashi, J. McGee, and R. Brown Effect of chronic treatment with the calcium antagonist diltiazem in Duchenne muscular dystrophy Neurology 38 1988 609 613
47. W. Pernice, R. Beckmann, U.P. Ketelsen, M. Frey, B. Schmidt-Redemann, and K.P. Haap A double-blind placebo controlled trial of diltiazem in Duchenne dystrophy Klin Wochenschr 66 1988 565 570
48. P.L. Johnson, and S.K. Bhattacharya Regulation of membrane-mediated chronic muscle degeneration in dystrophic hamsters by calcium-channel blockers: diltiazem, nifedipine and verapamil J Neurol Sci 115 1993 76 90
49. S.K. Bhattacharya, P.L. Johnson, and J.H. Thakar Reversal of impaired oxidative phosphorylation and calcium overloading in the skeletal muscle mitochondria of CHF-146 dystrophic hamsters Mol Chem Neuropathol 34 1998 53 77
50. R.D. Cohn, M. Durbeej, S.A. Moore, R. Coral-Vazquez, S. Prouty, and K.P. Campbell Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex J Clin Invest 107 2001 R1 R7
51. A.R. Dehpour, K. Mousavizadeh, and S. Gerayesh-Nejad Calcium release by diltiazem from isolated sarcoplasmic reticulum of rabbit skeletal muscle Gen Pharmacol 31 1998 463 468
52. S.K. Kong, K.P. Fung, Y.M. Choy, and C.Y. Lee Slow increase in intranuclear and cytosolic free calcium concentrations in L929 cells is important in tumour necrosis factor-alpha-mediated cell death Oncology 54 1997 55 62
53. D. Crenesse, K. Tornieri, M. Laurens, C. Heurteaux, R. Cursio, and J. Gugenheim Diltiazem reduces apoptosis in rat hepatocytes subjected to warm hypoxia-reoxygenation Pharmacology 65 2002 87 95
54. D.L. Lefkowitz, and S.S. Lefkowitz Macrophage-neutrophil interaction: a paradigm for chronic inflammation revisited Immunol Cell Biol 79 2001 502 506